JP2024508823A5 - - Google Patents
Info
- Publication number
- JP2024508823A5 JP2024508823A5 JP2023551984A JP2023551984A JP2024508823A5 JP 2024508823 A5 JP2024508823 A5 JP 2024508823A5 JP 2023551984 A JP2023551984 A JP 2023551984A JP 2023551984 A JP2023551984 A JP 2023551984A JP 2024508823 A5 JP2024508823 A5 JP 2024508823A5
- Authority
- JP
- Japan
- Prior art keywords
- segment
- seq
- lcmv
- glycoprotein
- sequence identity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21159746 | 2021-02-26 | ||
| EP21159746.3 | 2021-02-26 | ||
| PCT/EP2022/054766 WO2022180203A1 (en) | 2021-02-26 | 2022-02-25 | New virus particles for therapeutic purposes |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024508823A JP2024508823A (ja) | 2024-02-28 |
| JP2024508823A5 true JP2024508823A5 (enExample) | 2025-02-25 |
Family
ID=74844711
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023551984A Pending JP2024508823A (ja) | 2021-02-26 | 2022-02-25 | 治療目的のための新規のウイルス粒子 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20220273741A1 (enExample) |
| EP (1) | EP4297763A1 (enExample) |
| JP (1) | JP2024508823A (enExample) |
| KR (1) | KR20230153411A (enExample) |
| CN (1) | CN117241812A (enExample) |
| AU (1) | AU2022226407A1 (enExample) |
| CA (1) | CA3208055A1 (enExample) |
| CL (1) | CL2023002508A1 (enExample) |
| IL (1) | IL305349A (enExample) |
| MX (1) | MX2023009650A (enExample) |
| WO (1) | WO2022180203A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025046106A1 (en) | 2023-08-31 | 2025-03-06 | Abalos Therapeutics Gmbh | Virus particles with improved entry into tumor cells |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102004034461B4 (de) * | 2004-07-16 | 2008-02-07 | Chemotherapeutisches Forschungsinstitut Georg-Speyer-Haus | Gentherapie solider Tumore durch retrovirale, mit Arenavirus-Glykoprotein pseudotypisierte Vektoren |
| DE102015207036A1 (de) | 2015-04-17 | 2016-10-20 | Karl Sebastian Lang | Arenaviren zur Anwendung bei der Behandlung und/oder Vorbeugung von Tumoren sowie Verfahren zur Herstellung von Arenaviren mit (verbesserten) tumorregressiven Eigenschaften |
| EP3373959B1 (en) * | 2015-11-12 | 2022-06-29 | Hookipa Biotech GmbH | Arenavirus particles as cancer vaccines |
| DE102018215551A1 (de) * | 2018-09-12 | 2020-03-12 | Virolutions Biotech Gmbh | Verfahren zur Herstellung eines antitumoralen Arenavirus sowie Arenavirusmutanten |
-
2022
- 2022-02-25 JP JP2023551984A patent/JP2024508823A/ja active Pending
- 2022-02-25 CN CN202280030958.8A patent/CN117241812A/zh active Pending
- 2022-02-25 CA CA3208055A patent/CA3208055A1/en active Pending
- 2022-02-25 AU AU2022226407A patent/AU2022226407A1/en active Pending
- 2022-02-25 US US17/680,960 patent/US20220273741A1/en active Pending
- 2022-02-25 KR KR1020237032657A patent/KR20230153411A/ko active Pending
- 2022-02-25 EP EP22711182.0A patent/EP4297763A1/en active Pending
- 2022-02-25 IL IL305349A patent/IL305349A/en unknown
- 2022-02-25 MX MX2023009650A patent/MX2023009650A/es unknown
- 2022-02-25 WO PCT/EP2022/054766 patent/WO2022180203A1/en not_active Ceased
-
2023
- 2023-08-24 CL CL2023002508A patent/CL2023002508A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Peng | Current status of gendicine in China: recombinant human Ad-p53 agent for treatment of cancers | |
| JP2025081522A (ja) | 改変アデノウイルス | |
| JP2021520203A5 (enExample) | ||
| TW201920236A (zh) | 用於對ｈｂｖ產生免疫反應之類病毒粒子 | |
| JP2022524391A5 (enExample) | ||
| JP2008533988A5 (enExample) | ||
| JP2009511482A5 (enExample) | ||
| JP7150611B2 (ja) | 腫瘍関連抗原に対する免疫応答を誘起するための組成物及び方法 | |
| CN108025054A (zh) | 用于治疗和/或预防肿瘤的沙粒病毒和用于制备具有（改善的）肿瘤消退性能的沙粒病毒的方法 | |
| AU2018303064B2 (en) | Virus for treating tumors | |
| KR102768669B1 (ko) | 종양 치료용 콕삭키바이러스 b | |
| EP2826856B1 (en) | Genetically stable oncolytic RNA virus, method of manufacturing and use thereof | |
| JP2022500054A (ja) | 抗腫瘍アレナウイルスおよびアレナウイルス変異体を生産するための方法 | |
| JP2022500054A5 (enExample) | ||
| WO2024114576A1 (zh) | 用于治疗肿瘤的柯萨奇b组1型病毒 | |
| CN112641811A (zh) | 一种抗肿瘤病毒 | |
| JP7373168B2 (ja) | 腫瘍を治療するためのエコーウイルス | |
| WO2020238427A1 (zh) | 特异杀伤肿瘤细胞的溶瘤病毒系统及其应用 | |
| CN114569743B (zh) | 肝特异性的基因编辑纳米药物及其制备方法和应用 | |
| JP7543277B2 (ja) | 腫瘍溶解性ワクシニアウイルス | |
| CN116463299A (zh) | 重组西尼罗河减毒病毒的疫苗、药物及应用 | |
| CN1429846A (zh) | 肿瘤新生血管特异性结合多肽与人α干扰素融合蛋白及制备 | |
| CN107759673B (zh) | 可对hbv的dna进行表观甲基化修饰的蛋白分子及其应用 | |
| CN115920006B (zh) | Abcf1或其激动剂在制备抗dna病毒制剂中的应用 | |
| CN103611168A (zh) | 一种靶向治疗肝癌的复合磁性纳米粒及制备方法 |